Canada approves Merck grass allergy immunotherapy

February 3, 2014 by The Associated Press

Merck & Co. says it's won its first approval for its new immunotherapy tablet for grass allergies, from regulators in Canada.

The drug, called Grastek, gradually reduced to grass pollen, by desensitizing the immune system to the substance triggering the allergic reaction. Most treatments just temporarily relieve sneezing, itching and other symptoms.

The world's third-biggest drugmaker, based in Whitehouse Station, N.J., has partnered with ALK-Abello to market it in North America. ALK-Abello sells it in Europe as Grazas.

In the U.S., the Food and Drug Administration is weighing approval of both Grastek and an immunotherapy tablet for ragweed allergies. The tablets dissolve under the tongue and are taken daily for a year or so.

They could become an alternative to months of uncomfortable allergy shots.

Explore further: Merck says FDA reviewing its ragweed allergy therapy

Related Stories

Merck says FDA reviewing its ragweed allergy therapy

May 8, 2013
Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, ...

Merck: FDA reviewing tablet to eliminate allergy

March 27, 2013
Drugmaker Merck & Co. says federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that gradually reduces allergy symptoms over time, rather than just temporarily relieving ...

FDA panel considers first pill for ragweed allergy

January 28, 2014
(HealthDay)—There may be good news coming in the form of a pill for the millions of Americans who suffer from ragweed allergy.

Allergy shots during pregnancy may decrease allergies in children

November 8, 2013
Expecting mothers who suffer from allergies may want to consider another vaccination in addition to the flu shot and Tdap. A study being presented at the Annual Scientific Meeting of the American College of Allergy, Asthma ...

Study demonstrates that once-a-day pill offers relief from ragweed allergy symptoms

May 7, 2013
An international team of researchers, led by physician-scientists at Johns Hopkins, reports that a once-daily tablet containing a high dose of a key ragweed pollen protein effectively blocks the runny noses, sneezes, nasal ...

DNA of peanut-allergic kids changes with immune therapy, study finds

January 31, 2014
Treating a peanut allergy with oral immunotherapy changes the DNA of the patient's immune cells, according to a new study from the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford. The ...

Recommended for you

Australian researchers in peanut allergy breakthrough

August 17, 2017
Australian researchers have reported a major breakthrough in the relief of deadly peanut allergy with the discovery of a long-lasting treatment they say offers hope that a cure will soon be possible.

Genetic variants found to play key role in human immune system

August 16, 2017
It is widely recognized that people respond differently to infections. This can partially be explained by genetics, shows a new study published today in Nature Communications by an international collaboration of researchers ...

Study identifies a new way to prevent a deadly fungal infection spreading to the brain

August 16, 2017
Research led by the University of Birmingham has discovered a way to stop a deadly fungus from 'hijacking' the body's immune system and spreading to the brain.

Biophysics explains how immune cells kill bacteria

August 16, 2017
(Tokyo, August 16) A new data analysis technique, moving subtrajectory analysis, designed by researchers at Tokyo Institute of Technology, defines the dynamics and kinetics of key molecules in the immune response to an infection. ...

How a nutrient, glutamine, can control gene programs in cells

August 15, 2017
The 200 different types of cells in the body all start with the same DNA genome. To differentiate into families of bone cells, muscle cells, blood cells, neurons and the rest, differing gene programs have to be turned on ...

Scientists identify gene that controls immune response to chronic viral infections

August 15, 2017
For nearly 20 years, Tatyana Golovkina, PhD, a microbiologist, geneticist and immunologist at the University of Chicago, has been working on a particularly thorny problem: Why are some people and animals able to fend off ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.